Site Selector Prospectus — 2026

Whitestown
Life Sciences
Campus

Indiana's Premier Life Sciences
Opportunity Site

3370 South 450 East  ·  Whitestown, Indiana  ·  Boone County  ·  View on Google Maps →

25.25 Total Acres
3 Contiguous Parcels
$21B Adjacent Anchor Investment
Aerial rendering of Whitestown Life Sciences Campus
12 mi to Eli Lilly Campus
Campus Flyover Rendering
3370 South 450 East  ·  Whitestown, Indiana
Conceptual rendering by DELV Design Studio, LLC · BD26-015 · Feb 2026
Three Site Plans · One Property
25.25 acres. Three buyer-ready paths forward.

Why Whitestown.
Why Now.
Why This Site.

Institutional developers and site selectors evaluating the Midwest life sciences corridor will find very few sites that meet the threshold of scale, infrastructure readiness, and strategic positioning that this one does. Here is why.

01
Direct Corridor Position
12 miles from Eli Lilly's $21B LEAP campus — the largest pharmaceutical manufacturing investment in U.S. history. This is not proximity. This is adjacency.
02
Infrastructure Advantage — Not a Promise
Water, sewer, gas, fiber, and electric capacity are active or advancing to this site now. Most competing sites in this corridor face 2+ year infrastructure delays. This site does not.
03
Speed to Market
Zoning and annexation support is active from the Town of Whitestown — a jurisdiction that is pro-development and moving fast. Weeks to permitting, not years. One of the few scalable sites in Indiana capable of supporting near-term life sciences development.
04
Between Labor and Research
21 miles to IU Indianapolis. 41 miles to Purdue University. 12 miles to Indianapolis Executive Airport. Positioned at the precise intersection of workforce, research, and logistics that life sciences operations demand.
05
State Investment Aligned
Indiana has committed $1B to life sciences growth under Governor Braun. This site is positioned to be a delivery mechanism for that commitment — not a beneficiary waiting for it.
The Opportunity
In the direct path of
unprecedented scale

A 25.25-acre site under single-family partnership ownership, positioned directly adjacent to one of the most significant pharmaceutical manufacturing expansions in U.S. history. This is not speculative — it is strategically inevitable.

$21B
Eli Lilly & Company Biomanufacturing Investment · Lebanon, Indiana

Representing the largest pharmaceutical manufacturing investment in U.S. history — anchoring an entire new life sciences corridor in Indiana, with this site positioned as its critical missing middle layer.

The state is all-in
on life sciences

$1 BILLION
State Investment in Indiana Life Sciences
Governor Mike Braun  ·  Announced March 17, 2026  ·  Goal: 100,000 New High-Wage Jobs Over 10 Years
"

Indiana is leading in life sciences, and today we're investing to accelerate that growth with the goal of creating 100,000 new high-wage jobs over the next 10 years. This investment will make Indiana the premier destination for human therapeutics, animal health, agritech, biotechnology, and environmental innovation.

— Governor Mike Braun, State of Indiana

"Indiana is home to a vital life sciences community, and we're proud to support the State in expanding it — creating jobs, advancing innovation, and improving lives for Hoosiers and people around the world."

David Ricks
Chairman & CEO, Eli Lilly and Company

"Purdue University is excited to support our state's economic growth by working with industry and state government to create jobs, talents, and innovation with excellence at scale — from Indianapolis and the One Health Innovation District to the LEAP District and Greater Lafayette."